Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children - 02/09/11
Doi : 10.1067/mpd.2001.109606
Robert M. Kline, PhD, Jeffrey J. Kline, MD, Joan Di Palma, MD, Giulio J. Barbero, MD† a
a From University of Missouri-Columbia, Department of Child Health, Division of Pediatric Gastroenterology, Columbia, Missouri; Pediatric Gastroenterology and Liver Disease Clinic, Charleston, South Carolina; and Hahnemann University, St Christopher’s Hospital, Division of Pediatric Gastroenterology, Philadelphia, Pennsylvania.
Abstract |
In a randomized, double-blind controlled trial, 42 children with irritable bowel syndrome (IBS) were given pH-dependent, enteric-coated peppermint oil capsules or placebo. After 2 weeks, 75% of those receiving peppermint oil had reduced severity of pain associated with IBS. Peppermint oil may be used as a therapeutic agent during the symptomatic phase of IBS. (J Pediatr 2001;138:125-8)
Le texte complet de cet article est disponible en PDF. | Supported in part by a grant from Tillotts Pharma AG, Ziefen, Switzerland. |
© 2001
Academic Press. Tous droits réservés.
Vol 138 - N° 1
P. 125-128 - janvier 2001 Retour au numéro
Article précédent
- Ornithine transcarbamylase deficiency and pancreatitis
- George Anadiotis, Lynne Ierardi-Curto, Paige B. Kaplan, Gerard T. Berry
- Growth hormone deficiency caused by pituitary stalk interruption in Fanconi’s anemia
- Sophie Dupuis-Girod, Eliane Gluckman, Jean-Claude Souberbielle, Raja Brauner
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?